Posted by Michael Wonder on 18 May 2018
FDA looking at ways to include price info in drug ads, Gottlieb says, as questions loom
18 May 2018 - The commissioner of the FDA, Scott Gottlieb, said a proposal to have pharmaceutical companies include drug prices in advertisements has prompted a series of questions, including exactly how consumers would benefit and whether the government can legally require the disclosures.
Gottlieb said an agency working group would consider questions like those as it seeks to implement one of the Trump administration’s top proposals for lowering drug prices.
“Does the disclosure of the price information provide appropriate balance to the consumer — like, is the information about the cost of the drug and the accessibility of the drug important at the time that they’re seeing the advertisement, in order to provide appropriate disclosure and fair balance in the advertisement?” Gottlieb said.
